FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Fibronectin is overexpressed in certain cancers and contributes to the tumorigenic process [52] contrary to our findings in BCR-ABL1T315I+ CML, where decreased levels of fibronectin exacerbate leukemia progression.